Evidence map›Paper›PMID 18395083›Full record

ArticleGastroenterology2008

Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis.

Giuseppe Mazzarella, Rosita Stefanile, Alessandra Camarca, Paolo Giliberti, Elena Cosentini, Caterina Marano, Gaetano Iaquinto, Nicola Giardullo, Salvatore Auricchio, Alessandro Sette and 2 more

Abstract readComparative Study
In one paragraph

Article in Gastroenterology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Dietary gluten triggers concomitant activation of CD4+ and CD8+ αβ T cells and γδ T cells in celiac disease.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Trial
  4. T cell receptors for antigen on intraepithelial cytolytic T lymphocytes in celiac disease engage enterocyte HLA-E and HLA-B.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Circulating CD103Mucosal immunology · 2021
    Article
  13. Regulation of peanut-specific CD8The Journal of allergy and clinical immunology · 2021
    Article
  14. Review
  15. New Insights on CD8Frontiers in immunology · 2021
    Review
  16. Article
  17. Review
  18. Review
  19. Coeliac Disease and Mast Cells.International journal of molecular sciences · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Giuseppe MazzarellaInstitute of Food Sciences, CNR, Avellino, Italy.
Rosita Stefanile
Alessandra Camarca
Paolo Giliberti
Elena Cosentini
Caterina Marano
Gaetano Iaquinto
Nicola Giardullo
Salvatore Auricchio
Alessandro Sette
Riccardo Troncone
Carmen Gianfrani
University of Naples Federico II · ITInstitute of Food Science · ITAzienda Ospedaliera S.Giuseppe Moscati · ITLa Jolla Institute for Immunology · US

Funding

DOMINANCE IN T CELL RESPONSES TO SMALLPOX VACCINATIONR01AI056268 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SETTE, ALESSANDRO D. · 2003 to 2006
$3.0M
NIAID NIH HHS R01 AI056268
6 · The paper itself

Abstract

BACKGROUND &

aimsThe extensive infiltration of CD8(+) T cells in the intestinal mucosa of celiac disease (CD) patients is a hallmark of the disease. We identified a gliadin peptide (pA2) that is selectively recognized by CD8(+) T cells infiltrating intestinal mucosa of HLA-A2(+) CD patients. Herein, we investigated the phenotype, the tissue localization, and the effector mechanism of cells responsive to pA2 by using the organ culture of CD intestinal mucosa. The target of pA2-mediated cytotoxicity was also investigated by using the intestinal epithelial cell lines Caco2 and HT29, A2(+) and A2(-), respectively, as target cells.

methodsJejunal biopsy specimens from CD patients were cultured in vitro with pA2, and cellular activation was evaluated by immunohistochemistry and cytofluorimetric analysis. Cytotoxicity of pA2-specific, intestinal CD8(+) T cells was assayed by granzyme-B and interferon-gamma release and by apoptosis of target cells.

resultspA2 challenge of A2(+) CD mucosa increased the percentage of CD8(+)CD25(+) and of CD80(+) cells in the lamina propria, the former mainly localized beneath the epithelium, as well as the number of terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling-positive cells (TUNEL(+)) in the epithelium. Intraepithelial CD3(+) cells and enterocyte expression of Fas were also increased. CD8(+)CD25(+) and CD8(+)FASL(+) T cells were significantly increased in cell preparations from biopsy specimens cultured with pA2. CD8(+) T-cell lines released both granzyme-B and interferon-gamma following recognition of pA2 when presented by Caco2 and not by HT29.

conclusionsThese data indicate that gliadins contain peptides able to activate, through a TCR/HLA class I interaction, CD8-mediated response in intestinal CD mucosa and to induce the enterocyte apoptosis.

Indexed as

AdultB7-1 AntigenBiopsyCD8-Positive T-LymphocytesCeliac DiseaseCells, CulturedEnterocytesEnzyme-Linked Immunosorbent Assayfas ReceptorFemaleFlow CytometryGliadinHLA-A2 AntigenHumansInterleukin-2 Receptor alpha SubunitJejunumB7-1 Antigenfas ReceptorGliadinHLA-A2 AntigenInterleukin-2 Receptor alpha Subunit

Identifiers

PMID18395083
PMCPMC3319059
OpenAlexW2111452470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.